{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,18]],"date-time":"2026-08-18T01:35:54Z","timestamp":1787016954535,"version":"build-2736575974"},"reference-count":22,"publisher":"Elsevier BV","issue":"7","license":[{"start":{"date-parts":[[2020,7,1]],"date-time":"2020-07-01T00:00:00Z","timestamp":1593561600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2020,7,1]],"date-time":"2020-07-01T00:00:00Z","timestamp":1593561600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2020,7,1]],"date-time":"2020-07-01T00:00:00Z","timestamp":1593561600000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/www.elsevier.com\/open-access\/userlicense\/1.0\/"}],"content-domain":{"domain":["international-journal-of-gynecological-cancer.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["International Journal of Gynecological Cancer"],"published-print":{"date-parts":[[2020,7]]},"DOI":"10.1136\/ijgc-2020-001254","type":"journal-article","created":{"date-parts":[[2020,6,9]],"date-time":"2020-06-09T05:59:32Z","timestamp":1591682372000},"page":"969-974","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":15,"title":["Expression of immune cell markers and tumor markers in patients with cervical cancer"],"prefix":"10.1016","volume":"30","author":[{"given":"Liming","family":"Zhang","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hui","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yuheng","family":"Huang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiaowei","family":"Xi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yunyan","family":"Sun","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1136\/ijgc-2020-001254_bb0010","first-page":"394","article-title":"Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries","volume":"68","author":"Bray","year":"2018","journal-title":"CA Cancer J Clin"},{"key":"10.1136\/ijgc-2020-001254_bb0015","doi-asserted-by":"crossref","first-page":"2436","DOI":"10.1002\/ijc.30382","article-title":"A global view on cancer incidence and national levels of the human development index","volume":"139","author":"Fidler","year":"2016","journal-title":"Int J Cancer"},{"key":"10.1136\/ijgc-2020-001254_bb0020","doi-asserted-by":"crossref","first-page":"889","DOI":"10.1016\/S0140-6736(13)60022-7","article-title":"Human papillomavirus and cervical cancer","volume":"382","author":"Crosbie","year":"2013","journal-title":"Lancet"},{"key":"10.1136\/ijgc-2020-001254_bb0025","doi-asserted-by":"crossref","first-page":"S4","DOI":"10.1016\/j.ygyno.2008.07.045","article-title":"Natural history and epidemiology of HPV infection and cervical cancer","volume":"110","author":"Castellsagu\u00e9","year":"2008","journal-title":"Gynecol Oncol"},{"key":"10.1136\/ijgc-2020-001254_bb0030","doi-asserted-by":"crossref","first-page":"7107","DOI":"10.4049\/jimmunol.1002756","article-title":"Human papillomavirus 16-associated cervical intraepithelial neoplasia in humans excludes CD8 T cells from dysplastic epithelium","volume":"185","author":"Trimble","year":"2010","journal-title":"J Immunol"},{"key":"10.1136\/ijgc-2020-001254_bb0035","doi-asserted-by":"crossref","DOI":"10.1186\/s13027-017-0166-1","article-title":"T- and NK-cell populations with regulatory phenotype and markers of apoptosis in circulating lymphocytes of patients with CIN3 or microcarcinoma of the cervix: evidence for potential mechanisms of immune suppression","volume":"12","author":"Kurmyshkina","year":"2017","journal-title":"Infect Agent Cancer"},{"key":"10.1136\/ijgc-2020-001254_bb0040","doi-asserted-by":"crossref","first-page":"59","DOI":"10.1038\/cmi.2010.56","article-title":"A reversed CD4\/CD8 ratio of tumor-infiltrating lymphocytes and a high percentage of CD4(+)FOXP3(+) regulatory T cells are significantly associated with clinical outcome in squamous cell carcinoma of the cervix","volume":"8","author":"Shah","year":"2011","journal-title":"Cell Mol Immunol"},{"key":"10.1136\/ijgc-2020-001254_bb0045","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0199034","article-title":"B lymphocytes can be activated to act as antigen presenting cells to promote anti-tumor responses","volume":"13","author":"Rossetti","year":"2018","journal-title":"PLoS One"},{"key":"10.1136\/ijgc-2020-001254_bb0050","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1007\/s00262-016-1919-1","article-title":"High-efficiency lysis of cervical cancer by allogeneic NK cells derived from umbilical cord progenitors is independent of HLA status","volume":"66","author":"Veluchamy","year":"2017","journal-title":"Cancer Immunol Immunother"},{"key":"10.1136\/ijgc-2020-001254_bb0055","doi-asserted-by":"crossref","first-page":"156","DOI":"10.1097\/IGC.0000000000000578","article-title":"Regulatory T cells suppress natural killer cell immunity in patients with human cervical carcinoma","volume":"26","author":"Chang","year":"2016","journal-title":"Int J Gynecol Cancer"},{"key":"10.1136\/ijgc-2020-001254_bb0060","first-page":"1","article-title":"Prognostic role of squamous cell carcinoma antigen in cervical cancer: a meta-analysis","volume":"2019","author":"Liu","year":"2019","journal-title":"Dis Markers"},{"key":"10.1136\/ijgc-2020-001254_bb0065","doi-asserted-by":"crossref","first-page":"451","DOI":"10.1034\/j.1600-0412.2002.810513.x","article-title":"Preoperative serum SCC, CA125, and CA19-9 levels and lymph node status in squamous cell carcinoma of the uterine cervix","volume":"81","author":"Takeda","year":"2002","journal-title":"Acta Obstet Gynecol Scand"},{"key":"10.1136\/ijgc-2020-001254_bb0070","doi-asserted-by":"crossref","first-page":"541","DOI":"10.1002\/1097-0142(19880801)62:3<541::AID-CNCR2820620317>3.0.CO;2-4","article-title":"Analysis of the levels of CA125, carcinoembryonic antigen, and CA19-9 in the cervical mucus for a detection of cervical adenocarcinoma","volume":"62","author":"Fujii","year":"1988","journal-title":"Cancer"},{"key":"10.1136\/ijgc-2020-001254_bb0075","doi-asserted-by":"crossref","first-page":"169","DOI":"10.1016\/S0140-6736(18)32470-X","article-title":"Cervical cancer","volume":"393","author":"Cohen","year":"2019","journal-title":"Lancet"},{"key":"10.1136\/ijgc-2020-001254_bb0080","doi-asserted-by":"crossref","first-page":"59","DOI":"10.3109\/00365513.2014.936683","article-title":"HPV and cervical cancer","volume":"244","author":"Petry","year":"2014","journal-title":"Scand J Clin Lab Invest Suppl"},{"key":"10.1136\/ijgc-2020-001254_bb0085","doi-asserted-by":"crossref","first-page":"97","DOI":"10.1016\/j.it.2010.12.006","article-title":"Immunotherapy for persistent viral infections and associated disease","volume":"32","author":"van der Burg","year":"2011","journal-title":"Trends Immunol"},{"key":"10.1136\/ijgc-2020-001254_bb0090","doi-asserted-by":"crossref","first-page":"635","DOI":"10.1038\/s41577-018-0044-0","article-title":"CD4+ T cell help in cancer immunology and immunotherapy","volume":"18","author":"Borst","year":"2018","journal-title":"Nat Rev Immunol"},{"key":"10.1136\/ijgc-2020-001254_bb0095","doi-asserted-by":"crossref","first-page":"8509","DOI":"10.1002\/jcp.27782","article-title":"CD8+ cytotoxic T lymphocytes in cancer immunotherapy: A review","volume":"234","author":"Farhood","year":"2019","journal-title":"J Cell Physiol"},{"key":"10.1136\/ijgc-2020-001254_bb0100","doi-asserted-by":"crossref","first-page":"142","DOI":"10.1016\/j.humimm.2003.12.001","article-title":"Nonantigen specific CD8+ T suppressor lymphocytes originate from CD8+CD28- T cells and inhibit both T-cell proliferation and CTL function","volume":"65","author":"Filaci","year":"2004","journal-title":"Hum Immunol"},{"key":"10.1136\/ijgc-2020-001254_bb0105","doi-asserted-by":"crossref","first-page":"4323","DOI":"10.4049\/jimmunol.179.7.4323","article-title":"Cd8+ CD28- T regulatory lymphocytes inhibiting T cell proliferative and cytotoxic functions infiltrate human cancers","volume":"179","author":"Filaci","year":"2007","journal-title":"J Immunol"},{"key":"10.1136\/ijgc-2020-001254_bb0110","doi-asserted-by":"crossref","first-page":"5597","DOI":"10.1158\/0008-5472.CAN-16-0431","article-title":"The emerging role of B cells in tumor immunity","volume":"76","author":"Tsou","year":"2016","journal-title":"Cancer Res"},{"key":"10.1136\/ijgc-2020-001254_bb0115","doi-asserted-by":"crossref","first-page":"3240","DOI":"10.1002\/eji.201141693","article-title":"Human papillomavirus entry into NK cells requires CD16 expression and triggers cytotoxic activity and cytokine secretion","volume":"41","author":"Renoux","year":"2011","journal-title":"Eur J Immunol"}],"container-title":["International Journal of Gynecological Cancer"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1048891X2400197X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1048891X2400197X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/syndication.highwire.org\/content\/doi\/10.1136\/ijgc-2020-001254","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,7,22]],"date-time":"2025-07-22T22:38:24Z","timestamp":1753223904000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1048891X2400197X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,7]]},"references-count":22,"journal-issue":{"issue":"7","published-print":{"date-parts":[[2020,7]]}},"alternative-id":["S1048891X2400197X"],"URL":"https:\/\/doi.org\/10.1136\/ijgc-2020-001254","relation":{},"ISSN":["1048-891X"],"issn-type":[{"value":"1048-891X","type":"print"}],"subject":[],"published":{"date-parts":[[2020,7]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Expression of immune cell markers and tumor markers in patients with cervical cancer","name":"articletitle","label":"Article Title"},{"value":"International Journal of Gynecological Cancer","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1136\/ijgc-2020-001254","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2020 IGCS and ESGO 2020. No commercial re-use. See rights and permissions. Published by BMJ.","name":"copyright","label":"Copyright"}]}}